| Title: |
Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors |
| Authors: |
Stathis, AnastasiosAff1, IDs10637022013263_cor1; Tolcher, Anthony W.Aff2; Wang, Judy S.Aff3; Renouf, Daniel J.Aff4; Chen, Lin-ChiAff5; Suttner, Leah H.Aff5; Freshwater, TomokoAff5; Webber, Andrea L.Aff5; Nayak, TapanAff5; Siu, Lillian L.Aff6 |
| Source: |
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 41(3):380-390 |
| Database: |
Springer Nature Journals |